← FDA DRUG APPROVALS

FDA ANDA · ANDA040182

HYDROCODONE BITARTRATE AND ACETAMINOPHEN

Sponsor: PHARM ASSOC

APPLICATION
ANDA040182
TYPE
ANDA
ORIGINAL APPROVAL
1998-03-13
LATEST ACTION
1998-03-13
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

HYDROCODONE BITARTRATE AND ACETAMINOPHENDiscontinued
ACETAMINOPHEN 500MG/15ML, HYDROCODONE BITARTRATE 7.5MG/15ML · SOLUTION · ORAL

Approval history

1998-03-13OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →